1. Home
  2. ULY vs ACXP Comparison

ULY vs ACXP Comparison

Compare ULY & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ULY
  • ACXP
  • Stock Information
  • Founded
  • ULY 2013
  • ACXP 2017
  • Country
  • ULY United States
  • ACXP United States
  • Employees
  • ULY N/A
  • ACXP N/A
  • Industry
  • ULY
  • ACXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • ULY
  • ACXP Health Care
  • Exchange
  • ULY Nasdaq
  • ACXP Nasdaq
  • Market Cap
  • ULY 7.4M
  • ACXP 8.4M
  • IPO Year
  • ULY N/A
  • ACXP 2021
  • Fundamental
  • Price
  • ULY $5.72
  • ACXP $0.43
  • Analyst Decision
  • ULY Strong Buy
  • ACXP Strong Buy
  • Analyst Count
  • ULY 1
  • ACXP 2
  • Target Price
  • ULY $12.00
  • ACXP $10.00
  • AVG Volume (30 Days)
  • ULY 1.3M
  • ACXP 18.4M
  • Earning Date
  • ULY 08-11-2025
  • ACXP 08-08-2025
  • Dividend Yield
  • ULY N/A
  • ACXP N/A
  • EPS Growth
  • ULY N/A
  • ACXP N/A
  • EPS
  • ULY N/A
  • ACXP N/A
  • Revenue
  • ULY $134,085,000.00
  • ACXP N/A
  • Revenue This Year
  • ULY N/A
  • ACXP N/A
  • Revenue Next Year
  • ULY $23.08
  • ACXP N/A
  • P/E Ratio
  • ULY N/A
  • ACXP N/A
  • Revenue Growth
  • ULY N/A
  • ACXP N/A
  • 52 Week Low
  • ULY $2.99
  • ACXP $0.30
  • 52 Week High
  • ULY $22.50
  • ACXP $3.33
  • Technical
  • Relative Strength Index (RSI)
  • ULY 53.94
  • ACXP 47.99
  • Support Level
  • ULY $4.00
  • ACXP $0.52
  • Resistance Level
  • ULY $9.42
  • ACXP $0.63
  • Average True Range (ATR)
  • ULY 0.80
  • ACXP 0.09
  • MACD
  • ULY 0.34
  • ACXP 0.00
  • Stochastic Oscillator
  • ULY 41.70
  • ACXP 17.33

About ULY Urgent.ly Inc.

Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

Share on Social Networks: